drugset / Trial / NCT01256021
The Efficacy and Safety of MEDITOXIN® in Children With Cerebral Palsy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Meditoxin® in the treatment of children with cerebral palsy.
Timeline
- Start
- 2010-08
- Primary completion
- 2011-02
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 4 iu/kg | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 6 iu/kg | Intramuscular |